Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6247)
All Articles published online
|
Publishing Process of This Article
|
Oct 21, 2013 (publication date) through Apr 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cicala M, Emerenziani S, Guarino MPL, Ribolsi M. Proton pump inhibitor resistance, the real challenge in gastro-esophageal reflux disease. World J Gastroenterol 2013; 19(39): 6529-6535 [PMID: 24151377 DOI: 10.3748/wjg.v19.i39.6529] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i39/6529.htm |
| Number | Citing Articles |
| 1 |
Hiroto Miwa, Takashi Kondo, Tadayuki Oshima. Gastroesophageal reflux disease-related and functional heartburn. Current Opinion in Gastroenterology 2016; 32(4): 344 doi: 10.1097/MOG.0000000000000282
|
| 2 |
Zilla H Hussain, Emily E Henderson, Carla Maradey-Romerao, Nina George, Ronnie Fass, Brian E Lacy. The Proton Pump Inhibitor Non-Responder: A Clinical Conundrum. Clinical and Translational Gastroenterology 2015; 6(8): e106 doi: 10.1038/ctg.2015.32
|
| 3 |
Katsuhiko Iwakiri, Yuuichi Sakurai, Madoka Shiino, Hiroyuki Okamoto, Kentaro Kudou, Akira Nishimura, Naoki Hiramatsu, Eiji Umegaki, Kiyoshi Ashida. A randomized, double-blind study to evaluate the acid-inhibitory effect of vonoprazan (20 mg and 40 mg) in patients with proton-pump inhibitor-resistant erosive esophagitis. Therapeutic Advances in Gastroenterology 2017; 10(6): 439 doi: 10.1177/1756283X17705329
|
| 4 |
Diana M. Orbelo, Felicity T. Enders, Yvonne Romero, Dawn L. Francis, Sami R. Achem, Tushar S. Dabade, Michael D. Crowell, Debra M. Geno, Ramona S. DeJesus, Vikneswaran Namasivayam, Steven C. Adamson, Amindra S. Arora, Andrew J. Majka, Jeffrey A. Alexander, Joseph A. Murray, Matthew Lohse, Nancy N. Diehl, Mary Fredericksen, Kee Wook Jung, Margaret S. Houston, Angela E. O’Neil, David A. Katzka. Once-Daily Omeprazole/Sodium Bicarbonate Heals Severe Refractory Reflux Esophagitis with Morning or Nighttime Dosing. Digestive Diseases and Sciences 2015; 60(1): 146 doi: 10.1007/s10620-013-3017-y
|
| 5 |
M. Ribolsi, P. Balestrieri, R. H Holloway, S. Emerenziani, M. Cicala. Intra-bolus pressure and esophagogastric gradient, assessed with high-resolution manometry, are associated with acid exposure and proximal migration of refluxate. Diseases of the Esophagus 2016; 29(8): 1020 doi: 10.1111/dote.12434
|
| 6 |
I V Maev, E V Barkalova, M A Ovsepyan, Yu A Kucheryavyi, D N Andreev. Possibilities of pH impedance and high-resolution manometry in managing patients with refractory gastroesophageal reflux disease. Terapevticheskii arkhiv 2017; 89(2): 76 doi: 10.17116/terarkh201789276-83
|
| 7 |
N B Lishchuk, V I Simanenkov, S V Tikhonov. Differentiation therapy for non-acidic gastroesophageal reflux disease. Terapevticheskii arkhiv 2017; 89(4): 57 doi: 10.17116/terarkh201789457-63
|
| 8 |
Marzio Frazzoni, Micaela Piccoli, Rita Conigliaro, Leonardo Frazzoni, Gianluigi Melotti. Laparoscopic fundoplication for gastroesophageal reflux disease. World Journal of Gastroenterology 2014; 20(39): 14272-14279 doi: 10.3748/wjg.v20.i39.14272
|
| 9 |
Qian Jun Zhuang, Nian Di Tan, Song Feng Chen, Meng Yu Zhang, Ying Lian Xiao. Magnetic sphincter augmentation in treating refractory gastroesophageal reflux disease: A systematic review and meta‐analysis. Journal of Digestive Diseases 2021; 22(12): 695 doi: 10.1111/1751-2980.13063
|
| 10 |
Bibek Das, Marcus Reddy, Omar A. Khan. Is the Stretta procedure as effective as the best medical and surgical treatments for gastro-oesophageal reflux disease? A best evidence topic. International Journal of Surgery 2016; 30: 19 doi: 10.1016/j.ijsu.2016.03.062
|
| 11 |
Roman Vasiliev, Igor Maev Igor Maev, Igor Bakulin, Dmitriy Bordin Dmitriy Bordin, Nataliya Bakulina, Inna Oganezova, Ekaterina Skazyvaeva, Maria Skalinskaya, Yulia Embutnieks Yulia Embutnieks, Roman Plavnik, Lyudmila Fedulenkova Lyudmila Fedulenkova, Sergey Tikhonov, Mariia Zhuravleva Mariia Zhuravleva. Epidemiological and clinical risk factors for non-erosive reflux disease, erosive esophagitis and Barrett’s esophagus in Russia. Gastroenterology & Hepatology: Open Access 2021; 12(6): 176 doi: 10.15406/ghoa.2021.12.00482
|
| 12 |
Woretaw Sisay Zewdu, Tezera Jemere Aragaw. <p>Evaluation of the Anti-Ulcer Activity of Hydromethanolic Crude Extract and Solvent Fractions of the Root of <em>Rumex nepalensis</em> in Rats</p>. Journal of Experimental Pharmacology 2020; : 325 doi: 10.2147/JEP.S258586
|
| 13 |
J. Sunwoo, J. Oh, S. J. Moon, S. C. Ji, S. H. Lee, K.‐S. Yu, H. S. Kim, A. Lee, I.‐J. Jang. Safety, tolerability, pharmacodynamics and pharmacokinetics of DWP14012, a novel potassium‐competitive acid blocker, in healthy male subjects. Alimentary Pharmacology & Therapeutics 2018; 48(2): 206 doi: 10.1111/apt.14818
|
| 14 |
I. V. Maev, E. V. Barkalova, M. A. Hovsepyan, Yu. A. Kucheryavy, Dmitry N. Andreyev. Esophageal manometry high-resolution in
clinical practice.. Clinical Medicine (Russian Journal) 2018; 95(12): 1127 doi: 10.18821/0023-2149-2017-95-12-1127-1136
|
| 15 |
Akinari Sawada, Daniel Sifrim, Yasuhiro Fujiwara. Esophageal Reflux Hypersensitivity: A Comprehensive Review. Gut and Liver 2023; 17(6): 831 doi: 10.5009/gnl220373
|
| 16 |
Ryo Kato, Kiyokazu Nakajima, Tsuyoshi Takahashi, Yasuhiro Miyazaki, Tomoki Makino, Yukinori Kurokawa, Makoto Yamasaki, Shuji Takiguchi, Masaki Mori, Yuichiro Doki. A case of advanced systemic sclerosis with severe GERD successfully treated with acotiamide. Surgical Case Reports 2016; 2(1) doi: 10.1186/s40792-016-0162-5
|
| 17 |
Zhengcai Lou. It is vital to identify the underlying cause of chronic laryngopharyngeal neuropathy. American Journal of Otolaryngology 2018; 39(1): 74 doi: 10.1016/j.amjoto.2017.11.001
|
| 18 |
S. Yi, H. Lee, S. B. Jang, H. M. Byun, S. H. Yoon, J.‐Y. Cho, I.‐J. Jang, K.‐S. Yu. A novel K+ competitive acid blocker, YH4808, sustains inhibition of gastric acid secretion with a faster onset than esomeprazole: randomised clinical study in healthy volunteers. Alimentary Pharmacology & Therapeutics 2017; 46(3): 337 doi: 10.1111/apt.14148
|
| 19 |
Neha Deshpande, Sharanya V., Ravi Kanth V. V., Murthy H. V. V., Sasikala M., Rupa Banerjee, Manu Tandan, Nageshwar Reddy D.. Rapid and ultra-rapid metabolizers with CYP2C19 *17 polymorphism do not respond to standard therapy with proton pump inhibitors. Meta Gene 2016; 9: 159 doi: 10.1016/j.mgene.2016.06.004
|
| 20 |
Elisa Marabotto, Andrea Pasta, Francesco Calabrese, Mentore Ribolsi, Amir Mari, Vincenzo Savarino, Edoardo Vincenzo Savarino. The Clinical Spectrum of Gastroesophageal Reflux Disease: Facts and Fictions. Visceral Medicine 2024; : 1 doi: 10.1159/000536583
|
| 21 |
Kayo Akutagawa, Ryuichi Iwakiri, Megumi Hara, Kazuma Fujimoto, Yasuhiro Fujiwara, Masahiko Inamori, Junji Tanaka, Tomohiko Shimatani, Junichi Akiyama, Takashi Ando, Noriaki Manabe, Fukunori Kinjo, Ryuzo Deguchi, Motoyasu Kusano. Risk factors for low response to proton-pump inhibitor treatment in reflux esophagitis and non-erosive reflux disease evaluated by the frequency scale for the symptoms of gastroesophageal reflux disease. Esophagus 2015; 12(3): 225 doi: 10.1007/s10388-014-0477-x
|
| 22 |
Zhi-Tong Li, Feng Ji, Xin-Wei Han, Rui Zhang, Li-Dong Chen, Chun-Xia Li, Li-Li Yuan, Zhong-Gao Wang, Kang-Dong Liu. Endoscopic cardial constriction with band ligation in the treatment of refractory gastroesophageal reflux disease: a preliminary feasibility study. Surgical Endoscopy 2021; 35(7): 4035 doi: 10.1007/s00464-021-08397-y
|
| 23 |
Yue Hu, Meng Zhang, Bin Lu, Jinfeng Dai. Helicobacter pylori and Antibiotic Resistance, A Continuing and Intractable Problem. Helicobacter 2016; 21(5): 349 doi: 10.1111/hel.12299
|
| 24 |
I. G. Pakhomova. Comorbid patient with GERD and cardiovascular disease receiving antiplatelet therapy. The possibilities of choosing a proton pump inhibitor on a case study. Medical Council 2019; (14): 10 doi: 10.21518/2079-701X-2019-14-10-16
|
| 25 |
Hai-Xiang Yu, Chun-Shan Han, Jin-Ru Xue, Zhi-Feng Han, Hua Xin. Esophageal hiatal hernia: risk, diagnosis and management. Expert Review of Gastroenterology & Hepatology 2018; 12(4): 319 doi: 10.1080/17474124.2018.1441711
|
| 26 |
Mengyu Zhang, Minhu Chen, Sui Peng, Yinglian Xiao. The Rome IV versus Rome III criteria for heartburn diagnosis: A comparative study. United European Gastroenterology Journal 2018; 6(3): 358 doi: 10.1177/2050640617735084
|
| 27 |
T. V. K. Herregods, M. Troelstra, P. W. Weijenborg, A. J. Bredenoord, A. J. P. M. Smout. Patients with refractory reflux symptoms often do not have GERD. Neurogastroenterology & Motility 2015; 27(9): 1267 doi: 10.1111/nmo.12620
|
| 28 |
Nicola de Bortoli, Marzio Frazzoni, Edoardo Savarino. Diagnosis and Endoscopic Management of Digestive Diseases. 2017; : 217 doi: 10.1007/978-3-319-42358-6_14
|
| 29 |
Yoshimasa Hoshikawa, Shintaro Hoshino, Noriyuki Kawami, Katsuhiko Iwakiri. Prevalence of behavioral disorders in patients with vonoprazan-refractory reflux symptoms. Journal of Gastroenterology 2021; 56(2): 117 doi: 10.1007/s00535-020-01751-2
|
| 30 |
Ying-Nan Li, Xiao-Ning Zhao, Ting-Ting Li, Chang-Zheng Wang, Wei-Hua Wang, Lei Tian, Ben-Yan Wu. Clinical Characteristics of Elderly Patients with Refractory Gastroesophageal Reflux Disease. International Journal of Gerontology 2016; 10(2): 100 doi: 10.1016/j.ijge.2015.03.003
|
| 31 |
Shiyu Zhang, Xiaoyan Wang, Xuelian Xiang, Huiying Yang, Nana Tang, Li Liu, Bo Jiang. A Prospective Trial to Access the Optimal Circumference of Resection in Antireflux Mucosectomy for Treatment-refractory GERD. Journal of Clinical Gastroenterology 2022; 56(5): 401 doi: 10.1097/MCG.0000000000001650
|
| 32 |
Kornilia Nikaki, Anna Rybak, Kenichiro Nakagawa, David Rawat, Etsuro Yazaki, Philip Woodland, Osvaldo Borrelli, Daniel Sifrim. Rumination Syndrome in Children Presenting With Refractory Gastroesophageal Reflux Symptoms. Journal of Pediatric Gastroenterology and Nutrition 2020; 70(3): 330 doi: 10.1097/MPG.0000000000002569
|
| 33 |
Yu. V. Evsyutina, A. S. Trukhmanov. Inadequate response to proton pump inhibitor therapy: Causes and patient management tactics. Terapevticheskii arkhiv 2015; 87(2): 85 doi: 10.17116/terarkh201587285-89
|
| 34 |
Jérôme R. Lechien, Francois Bobin, Vinciane Muls, Francois Mouawad, Giovanni Dapri, Didier Dequanter, Mihaela Horoi, Marie‐Paule Thill, Alexandra Rodriguez Ruiz, Sven Saussez. Changes of Laryngeal and Extralaryngeal Symptoms and Findings in Laryngopharyngeal Reflux Patients. The Laryngoscope 2021; 131(6): 1332 doi: 10.1002/lary.28962
|
| 35 |
Jiten P. Kothadia, Colin W. Howden. Potassium-Competitive Acid Blockers for the Treatment of Gastroesophageal Reflux Disease. Foregut: The Journal of the American Foregut Society 2024; 4(1): 7 doi: 10.1177/26345161231181357
|
| 36 |
A. V. Paraskevova, A. S. Trukhmanov, O. A. Storonova, S. V. Lyamina, S. V. Kalish, S. S. Pirogov, A. B. Ponomarev, D. E. Rumyantseva, I. Yu. Malyshev, I. V. Maev, V. T. Ivashkin. Macrophage phenotype after human refluxate exposure, esophageal dysmotility and their correlation with gastroesophageal reflux disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2022; 32(1): 24 doi: 10.22416/1382-4376-2022-32-1-24-33
|
| 37 |
Yung Lee, Umair Tahir, Lea Tessier, Kevin Yang, Taaha Hassan, Jerry Dang, Matthew Kroh, Dennis Hong. Long-term outcomes following Dor, Toupet, and Nissen fundoplication: a network meta-analysis of randomized controlled trials. Surgical Endoscopy 2023; 37(7): 5052 doi: 10.1007/s00464-023-10151-5
|
| 38 |
Mentore Ribolsi, Michele Cicala, Patrizia Zentilin, Matteo Neri, Aurelio Mauro, Konstantinos Efthymakis, Tommasangelo Petitti, Vincenzo Savarino, Roberto Penagini. Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non‐erosive reflux disease. Alimentary Pharmacology & Therapeutics 2018; 48(10): 1074 doi: 10.1111/apt.14986
|
| 39 |
Wei-Tao Liang, Zhong-Gao Wang, Feng Wang, Yue Yang, Zhi-Wei Hu, Jian-Jun Liu, Guang-Chang Zhu, Chao Zhang, Ji-Min Wu. Long-term outcomes of patients with refractory gastroesophageal reflux disease following a minimally invasive endoscopic procedure: a prospective observational study. BMC Gastroenterology 2014; 14(1) doi: 10.1186/1471-230X-14-178
|
| 40 |
Xu Han, Yawen Zhang, Allen Lee, Zhaoshen Li, Jun Gao, Xiaoyin Wu, Jiulong Zhao, Hui Wang, Di Chen, Duowu Zou, Chung Owyang. Upregulation of acid sensing ion channels is associated with esophageal hypersensitivity in GERD. The FASEB Journal 2022; 36(1) doi: 10.1096/fj.202100606R
|
| 41 |
Ying Lian Xiao, Meng Yu Zhang, Nian Di Tan, Song Feng Chen, Qian Jun Zhuang, Min Hu Chen. Patient‐ and physician‐reported satisfaction with gastroesophageal reflux disease (GERD) treatment in Chinese clinical practice. Journal of Digestive Diseases 2022; 23(5-6): 262 doi: 10.1111/1751-2980.13104
|
| 42 |
H. Jenkins, Y. Sakurai, A. Nishimura, H. Okamoto, M. Hibberd, R. Jenkins, T. Yoneyama, K. Ashida, Y. Ogama, S. Warrington. Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK‐438 (vonoprazan), a novel potassium‐competitive acid blocker, in healthy male subjects. Alimentary Pharmacology & Therapeutics 2015; 41(7): 636 doi: 10.1111/apt.13121
|
| 43 |
Mentore Ribolsi, Edoardo Savarino. Towards a better diagnosis of gastro esophageal reflux disease. Expert Review of Gastroenterology & Hepatology 2023; 17(10): 999 doi: 10.1080/17474124.2023.2267435
|
| 44 |
Arthur Laquière, Felix Trottier-Tellier, Romina Urena-Campos, Pascal Lienne, Laurence Lecomte, Maria Katsogiannou, Guillaume Penaranda, Christian Boustière, Masanao Nakamura. Evaluation of Antireflux Mucosectomy for Severe Gastroesophageal Reflux Disease: Medium-Term Results of a Pilot Study. Gastroenterology Research and Practice 2022; 2022: 1 doi: 10.1155/2022/1606944
|
| 45 |
М. Ю. Попович. ЧАСТОТА ТА ОСОБЛИВОСТІ УРАЖЕННЯ ВЕРХНІХ ВІДДІЛІВ ШЛУНКОВО-КИШКОВОГО ТРАКТУ У ХВОРИХ ІЗ ЛІМФОПРОЛІФЕРАТИВНИМИ ЗАХВОРЮВАННЯМИ ТА ЗАЛІЗОДЕФІЦИТНОЮ АНЕМІЄЮ ЖИТЕЛІВ ЗАКАРПАТТЯ. Здобутки клінічної і експериментальної медицини 2023; (4): 125 doi: 10.11603/1811-2471.2023.v.i4.14307
|
| 46 |
Diana L. Snyder, David A. Katzka. Complex Gastroesophageal Reflux Disease. Gastro Hep Advances 2022; 1(3): 420 doi: 10.1016/j.gastha.2022.02.014
|
| 47 |
Marzio Frazzoni, Helga Bertani, Raffaele Manta, Vincenzo Giorgio Mirante, Leonardo Frazzoni, Rita Conigliaro, Gianluigi Melotti. Impairment of chemical clearance is relevant to the pathogenesis of refractory reflux oesophagitis. Digestive and Liver Disease 2014; 46(7): 596 doi: 10.1016/j.dld.2014.03.005
|
| 48 |
Rena Yadlapati, Michael Tye, Sabine Roman, Peter J. Kahrilas, Katherine Ritter, John E. Pandolfino. Postprandial High-Resolution Impedance Manometry Identifies Mechanisms of Nonresponse to Proton Pump Inhibitors. Clinical Gastroenterology and Hepatology 2018; 16(2): 211 doi: 10.1016/j.cgh.2017.09.011
|
| 49 |
Sundeep Lakhtakia, Aniruddha P Singh, Neeraj Singla, Sana F Memon, Duvvur N Reddy. Efficacy and safety of pantoprazole and itopride in patients with overlap of gastroesophageal reflux disease and dyspepsia: A prospective, open‐label, single‐arm pilot study. JGH Open 2024; 8(2) doi: 10.1002/jgh3.12988
|
| 50 |
Chao Zhang, Jimin Wu, Zhiwei Hu, Chao Yan, Xiang Gao, Weitao Liang, Diangang Liu, Fei Li, Zhonggao Wang, Masaru Katoh. Diagnosis and Anti-Reflux Therapy for GERD with Respiratory Symptoms: A Study Using Multichannel Intraluminal Impedance-pH Monitoring. PLOS ONE 2016; 11(8): e0160139 doi: 10.1371/journal.pone.0160139
|
| 51 |
Rishi D. Naik, Michael F. Vaezi. Recent advances in diagnostic testing for gastroesophageal reflux disease. Expert Review of Gastroenterology & Hepatology 2017; 11(6): 531 doi: 10.1080/17474124.2017.1309286
|
| 52 |
Prashanth Rawla, Tagore Sunkara, Andrew Ofosu, Vinaya Gaduputi. Potassium-competitive acid blockers - are they the next generation of proton pump inhibitors?. World Journal of Gastrointestinal Pharmacology and Therapeutics 2018; 9(7): 63-68 doi: 10.4292/wjgpt.v9.i7.63
|
| 53 |
Mentore Ribolsi, Antonio Giordano, Michele Pier Luca Guarino, Alessandro Tullio, Michele Cicala. New classifications of gastroesophageal reflux disease: an improvement for patient management?. Expert Review of Gastroenterology & Hepatology 2019; 13(8): 761 doi: 10.1080/17474124.2019.1645596
|
| 54 |
I V Maev, D N Andreev, Yu A Kucheryavyy, R I Shaburov. Current advances in the treatment of gastroesophageal reflux disease: a focus on esophageal protection. Terapevticheskii arkhiv 2019; 91(8): 4 doi: 10.26442/00403660.2019.08.000387
|
| 55 |
Farzaneh Banki. Gastroesophageal Reflux Disease: Critical Aspects of the History. Foregut: The Journal of the American Foregut Society 2023; 3(3): 290 doi: 10.1177/26345161231170287
|
| 56 |
Dong Kyu Kim, Keun-Ho Lee, Sung-jun Kim, Soo-Jin Kim, Song Jin Lee, Chi Hye Park, Bong-Tae Kim, Geun-Seog Song, Byoung-Seok Moon, Shin-Young Ryu. Effects of Tegoprazan, a Novel Potassium-Competitive Acid Blocker, on Rat Models of Gastric Acid–Related Disease. Journal of Pharmacology and Experimental Therapeutics 2019; 369(3): 318 doi: 10.1124/jpet.118.254904
|
| 57 |
Benjamin D. Rogers, C. Prakash Gyawali. Enhancing High-Resolution Esophageal Manometry. Gastroenterology Clinics of North America 2020; 49(3): 411 doi: 10.1016/j.gtc.2020.04.001
|
| 58 |
Tarek M. Yosef, Ahmed ElMetwally Ahmed, Ahmed Mansour, Mahmoud Ahmed AbuFayyoud, Ahmed M ElGhandour. Evaluation of serum levels of Interleukin-4 in Egyptian patients with refractory gastroesophageal reflux disease. Alexandria Journal of Medicine 2020; 56(1): 196 doi: 10.1080/20905068.2020.1845441
|
| 59 |
Alessio Ardizzone, Deborah Mannino, Giovanna Casili, Michela Campolo, Irene Paterniti, Marika Lanza, Alessia Filippone, Alberto Repici, Valentina Bova, Anna Paola Capra, Salvatore Cuzzocrea, Emanuela Esposito. Efficacy of an oral suspension containing xyloglucan and pea proteins on a murine model of gastroesophageal reflux disease. Phytotherapy Research 2024; 38(3): 1610 doi: 10.1002/ptr.8133
|